Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants
Information
- DOI:
- https://doi.org/10.1002/14651858.CD002311.pub3Copy DOI
- Database:
-
- Cochrane Database of Systematic Reviews
- Version published:
-
- 18 April 2012see what's new
- Type:
-
- Intervention
- Stage:
-
- Review
- Cochrane Editorial Group:
-
Cochrane Neonatal Group
- Copyright:
-
- Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Article metrics
Altmetric:
Cited by:
Authors
Contributions of authors
Drs Onland and D. van Kaam have full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Onland, van Kaam.
Acquisition of data: Onland, van Kaam.
Analysis and interpretation of data: Onland, Offringa, van Kaam.
Drafting of the manuscript: Onland, van Kaam.
Critical revision of the manuscript for important intellectual content: Onland, Offringa, van Kaam.
Stastical analysis: Onland.
Study supervision: Offringa, van Kaam
Sources of support
Internal sources
-
Department of Neonatology, AMC, Amsterdam, Netherlands.
-
Department of Pediatric Clinical Epidemiology, AMC, Netherlands.
External sources
-
Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health, Department of Health and Human Services, USA.
Editorial support of the Cochrane Neonatal Review Group has been funded with Federal funds from the Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health, Department of Health and Human Services, USA, under Contract No. HHSN275201100016C.
Declarations of interest
No financial disclosure to be declared. No potential conflicts of interest known.
Acknowledgements
Dr P Lister, Dr R Iles, Dr B Shaw, Dr F Ducharme for writing the previous version of this review, named "Inhaled steroids for neonatal chronic lung disease".
Dr David Schwartz, Dr T Giep, Prof M Silverman and Dr Spencer Brudno provided additional information for the previous version of this review.
Prof Silverman and Dr Jonsson provided precious additional data for this updated version of the review.
Ms Diane Haughton, Ms Yolanda Montagne and Prof Roger Soll of the Cochrane Neonatal Review Group.
Version history
| Published | Title | Stage | Authors | Version |
| 2022 Dec 15 | Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants | Review | Wes Onland, Martin Offringa, Anton Kaam | |
| 2017 Aug 24 | Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants | Review | Wes Onland, Martin Offringa, Anton van Kaam | |
| 2012 Apr 18 | Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants | Review | Wes Onland, Martin Offringa, Anton van Kaam | |
| 2010 Jan 20 | Inhaled steroids for neonatal chronic lung disease | Review | Paula Lister, Richard Iles, Ben NJ Shaw, Francine M Ducharme | |
| 1999 Oct 25 | Inhaled steroids for neonatal chronic lung disease | Review | Paula Lister, Richard Iles, Ben NJ Shaw, Francine Ducharme | |
Notes
Editorial responsibility for the review "Inhaled steroids for neonatal chronic lung disease" has been transferred to the Cochrane Neonatal Review Group from the Cochrane Airways Group.
A new team of review authors has been assigned ‐ Dr Wes Onland, Dr Anton Van Kaam, Dr Martin Offringa.
